SCHEMBL18148952

SCHEMBL18148952

C[C@@H]1O[C@@H](O)[C@@H](OC(=O)c2ccccc2)[C@H](OC(=O)c2ccccc2)[C@@H]1OC(=O)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LGALS9 O00182 1/20 0.46
LGALS1 P09382 1/20 0.46
LGALS3 P17931 1/20 0.46
LGALS7; LGALS7B P47929 1/20 0.46
PTPN1 P18031 2/20 0.42
TSHR P16473 1/20 0.42
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
F2 P00734 1/20 0.40
LMNA P02545 1/20 0.40
GAA P10253 1/20 0.40
CHRNA7 P36544 2/20 0.39
HTR3E A5X5Y0 1/20 0.39
HTR3B O95264 1/20 0.39
HTR3A P46098 1/20 0.39
HTR3D Q70Z44 1/20 0.39
HTR3C Q8WXA8 1/20 0.39
BCHE P06276 1/20 0.39
APOBEC3A P31941 1/20 0.38
APOBEC3G Q9HC16 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13714166 1.00 LGALS9 (0.46) LGALS9LGALS1LGALS3LGALS7; LGALS7BPTPN1
SCHEMBL12653015 1.00 LGALS9 (0.46) LGALS9LGALS1LGALS3LGALS7; LGALS7BPTPN1
SCHEMBL6221505 1.00 LGALS9 (0.46) LGALS9LGALS1LGALS3LGALS7; LGALS7BPTPN1
SCHEMBL19591662 1.00 LGALS9 (0.46) LGALS9LGALS1LGALS3LGALS7; LGALS7BPTPN1
SCHEMBL18296432 1.00 LGALS9 (0.46) LGALS9LGALS1LGALS3LGALS7; LGALS7BPTPN1
SCHEMBL6857875 1.00 LGALS9 (0.46) LGALS9LGALS1LGALS3LGALS7; LGALS7BPTPN1
SCHEMBL30185438 0.98 LGALS9 (0.47) LGALS9LGALS1LGALS3LGALS7; LGALS7BPTPN1
SCHEMBL14281132 0.94 ABCB1 (0.43) LGALS9LGALS1LGALS3LGALS7; LGALS7BPTPN1
SCHEMBL17682036 0.90 TSHR (0.47) LGALS9LGALS1LGALS3LGALS7; LGALS7BPTPN1
SCHEMBL12618658 0.90 TSHR (0.47) LGALS9LGALS1LGALS3LGALS7; LGALS7BPTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9889205-B2 Glucose-responsive insulin conjugates MERCK SHARP & DOHME CORP. (US) 2018-02-13 US disclosed
US-20160303244-A1 GLUCOSE-RESPONSIVE INSULIN CONJUGATES MERCK SHARP & DOHME CORP. (US) 2016-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160303244-A1 GLUCOSE-RESPONSIVE INSULIN CONJUGATES GPR119, INSR, IRS1 LGALS9 866/4885LGALS1 582/4885LGALS3 1046/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.